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Bianca K. Frogner1*, H.E. Frech III2 and Stephen T. Parente3
Abstract
Background: Rankings from the World Health Organization (WHO) place the US health care system as one of the
least efficient among Organization for Economic Cooperation and Development (OECD) countries. Researchers have
questioned this, noting simplistic or inappropriate methodologies, poor measurement choice, and poor control
variables. Our objective is to re-visit this question by using newer modeling techniques and a large panel of
OECD data.
Methods: We primarily use the OECD Health Data for 25 OECD countries. We compare results from stochastic
frontier analysis (SFA) and fixed effects models. We estimate total life expectancy as well as life expectancy at age
60. We explore a combination of control variables reflecting health care resources, health behaviors, and economic
and environmental factors.
Results: The US never ranks higher than fifth out of all 36 models, but is also never the very last ranked country
though it was close in several models. The SFA estimation approach produces the most consistent lead country,
but the remaining countries did not maintain a steady rank.
Discussion: Our study sheds light on the fragility of health system rankings by using a large panel and applying
the latest efficiency modeling techniques. The rankings are not robust to different statistical approaches, nor to
variable inclusion decisions.
Conclusions: Future international comparisons should employ a range of methodologies to generate a more
nuanced portrait of health care system efficiency.
Keywords: International comparison, Health systems, Stochastic frontier analysis, Efficiency, Life expectancy
Background
As key provisions of the 2010 Patient Protection and
Affordable Care Act (ACA) roll out in 2014, researchers
and policymakers will be asking whether the US health
care system is gaining efficiency. The ACA will increase
insurance coverage, which may increase workload of an
already overburdened primary care workforce [1–3].
Simultaneous adoption of health information technology
(or the use of computers to store, retrieve, share and use
health care information, data and knowledge) spurred by
the 2009 Health Information Technology for Economics
and Clinical Health (HITECH) Act has been reported to
add to workforce burdens, although the long-run goal is
to reduce administrative waste, and duplicative and un-
necessary services [4–6]. As these major changes take ef-
fect, efficiency may be an elusive goal in the near-term
for the US health care system. But even more elusive
may be finding a methodology to monitor the efficiency
of the US health care system.
The World Health Organization (WHO) published one
of the most recognized rankings of health care system
performance in the 2000 report titled Health Systems:
Improving Performance [7]. The US placed 37th out of
191, behind Costa Rica, on overall health system perform-
ance. The report has been criticized for its objectives, con-
founding of social influences with health care system
performance, poor data quality, and narrow scope in
methodology [8–10]. Some of these critics re-estimated ef-
ficiency and rankings, using different approaches, which
generally led to different rankings [9, 11, 12]. The US
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tended to rank higher in these newer studies, although
none placed the US at the top.
Since the 2000 WHO report, several studies have fo-
cused on the efficiency of the health care systems of in-
dustrialized countries [13–18]. These studies vary in their
choice of output measures and statistical approaches. The
most common, although not universal conclusion, is that
US still does not fare well compared to other member
countries of the Organization for Economic Cooperation
and Development (OECD).
Researchers continue to question whether the method-
ologies employed in all these aforementioned studies on
efficiency and rankings are strong enough to make valid
conclusions, and to what extent the limitations impact
the conclusions [19, 20]. In this paper, we re-visit the
question of whether the US health care system is effi-
cient relative to other industrialized health care systems.
Our research goals are to apply the recommendations
from past studies and capitalize on advancements in
modeling techniques to produce new results. We discuss
the sensitivity of our results to variations of the model
specifications, and how these variations affect the rank-
ing of the US.
In the next section we discuss the dataset used for our
analysis and our approach to choosing the variables in
our model. We then present the statistical approaches
used in the past, and the more recently available ap-
proaches, to rank countries. We compare the results of
the various permutations of input and output variables
along with statistical approaches, and discuss the impli-
cations of our results in the Discussion section.
Methods
Data
We primarily use data from the 2013 OECD Health
Data, which is a comprehensive health systems dataset
on 34 members of the OECD [21]. Although some data
are available as far back as 1960, for our variables of
interest, the most complete set of data runs from 1990
through 2010 (21 years). All data used in this study are
available for public use. This study is not human subject
research, and is not subject to Institutional Review
Board review. The set of countries included in our ana-
lyses varied due to the choice of variables and estimation
approaches. Our final set of countries includes 25 out of
the 34 countries, and excludes Canada, Chile, France,
Greece, Ireland, Netherlands, Portugal, Switzerland, and
Turkey, due to missing data.
Some of our country time series contains gaps of vary-
ing length. All international comparisons face this major
limitation given that not all countries report all variables
for all years; thus we have an unbalanced panel. We did
not impute values for missing data. Instead, we dropped
observations with missing data, which we considered in
our sensitivity analyses.
Our output measure is life expectancy in order to
match the approach used in other health system ranking
studies [14, 15, 18]. We estimated three output mea-
sures: 1) total life expectancy, 2) life expectancy at age
60 for males, and 3) life expectancy at age 60 for fe-
males. Total life expectancy by gender was not available,
nor was a combined gender measure of life expectancy
at age sixty. A limitation of total life expectancy is that
causes of death in the earlier years are more strongly re-
lated to social differences than to health care (e.g. drug
overdose, accidental injuries, perinatal conditions, and
homicide) [22]. Given this limitation, we also included
life expectancy at age sixty (for females and males) as an
output measure since the health care system plays an in-
creasingly important role at later stages in life and this
care may have an impact on the remaining life
expectancy.
We tested numerous combinations of 33 input variables
based on theory and empirical evidence estimating each of
our three output measures – total life expectancy, life ex-
pectancy at age 60 for males, and life expectancy at age 60
for females. Generally, we tested metrics for health care
resources, service utilization, lifestyle and risk behaviors,
environmental factors, and economic factors. Although
the OECD Health Data includes a wide range of potential
input variables, our final choice of variables was in part
determined due to availability of data and frequency of
data reporting (Table 1). Our final models included a com-
bination of the following 11 input variables: physicians per
1,000 capita (for which we manually inserted two recent
data points for the US from OECD cited data sources),
magnetic resonance imaging (MRI) and computed tomog-
raphy (CT) scanners per million population, years of
potential life lost (YPLL) from self-harm, homicide, trans-
portation, and alcohol use per 100,000 capita, calories
consumed per capita per day (adjusted for average popula-
tion height in centimeters), percent of the population fif-
teen years and older who smoked daily, cubic tons of total
nitrogen dioxide (adjusted for square meter of land), and
gross domestic product (GDP) per capita (in purchasing
power parities and deflated to 2005 dollars) [23–25]. We
applied the adjustments to calories for height as well as to
nitrogen dioxide to land mass in effort to provide more
meaningful comparisons across countries. We tested sev-
eral other input variables in our sensitivity analyses, which
we discuss in our Results section.
Estimation approach
We estimated technical efficiency of a health care sys-
tem by its ability to maximize the life expectancy of
its population using a minimum amount of health care
and non-health care inputs. We compared three
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Table 1 Percent data missing input variables for study countries
Categories Variables % Data Missing
Health care All US
N = 525 N = 21
Resources: Total hospital beds per 1,000 capita 19.1 4.8
Capital Acute care beds per 1,000 capita 17.3 4.8
Labor Total health employees per 1,000 capita 23.2 0.0
Total active doctors per 1,000 capita 16.2 0.0
Total general practitioners (GPs) per 1,000 capita 46.7 14.3
Total specialist doctors per 1,000 capita 54.5 14.3
Total professional active nurses per 1,000 capita 64.0 42.9
Utilization Total hospital discharges per 1,000 capita 34.7 4.8
Average length of stay in acute care (days) 15.4 0.0
Total doctor visits per capita 29.5 38.1
Service intensity Ratio of GPs to specialists 55.2 14.3
Ratio of nurses to doctors 70.1 42.9
Technology MRI scanners per million population 49.1 52.4
CT scanners per million population 47.8 66.7
Risk Factors
Chronic diseasea Percent mortality due to chronic disease 0.0 0.0
Percent years potential life lost (YPLL) due to chronic disease 0.0 0.0
Lifestyle and behaviors Calories consumed per capita
Per day 36.8 14.3
Per day per centimeter 41.7 14.3
Liters of alcohol consumed by individuals 15 years or older
Per day 26.5 4.8
Per day per centimeter 34.3 4.8
Average number of cigarettes smoked per smoker per day 62.7 4.8
Percent of population (15 years and older) smoking daily 46.7 4.8
Percent of youth (15 to 24 years old) smoking daily 64.6 4.8
Grams of tobacco consumed per capita 39.2 0.0
Percent population self-reported as obese 60.8 28.6
YPLL from assaults per 100,000 capita 7.1 9.5
YPLL from self-harm per 100,000 capita 6.7 9.5
YPLL from transportation per 100,000 capita 6.7 9.5
YPLL from alcohol use per 100,000 capita 9.9 9.5
YPLL from drug use per 100,000 capita 49.7 52.4
Environmental Total nitrogen dioxide (measured in cubic tons and deflated to 1990 values)
Per capita 27.8 0.0
Per square meter of land 5.9 0.0
Mobile (% total) 7.6 0.0
Stationary (% total) 7.6 0.0
aChronic disease includes mental health diseases, cancer, diabetes, chronic obstructive pulmonary disease, kidney disease, cerebrovascular disease, acute
myocardial infarction, and ischemic heart disease.
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estimation approaches: 1) country fixed effects (FE)
model, 2) country and time FE model, and 3) stochastic
frontier analysis (SFA). We applied each estimation ap-
proach to predict each of the three output measures of life
expectancy (i.e., total, at age 60 for males, and at age 60
for females) as a function of various permutations of the
input variables described above. In this paper, we present
the results from our final 36 models.
FE models are common approaches for estimating
technical efficiency of health care systems. To iden-
tify efficient countries, we compared the size of the
country FE component of the residual. The most
efficient country is defined as the country with the
largest positive residuals. In other words, efficient
countries have higher-than-predicted life expectan-
cies given the same set of inputs compared to other
countries. The least efficient country has the most
negative residuals, or lower-than-predicted life ex-
pectancies. A series of F-tests suggested that FE was
more appropriate than an ordinary least squares
(OLS) approach. Breusch-Pagan Lagrange Multiplier
tests suggested that random effects was also more
appropriate than an OLS approach. Hausman test
results support the use of FE over RE although the
variance matrix was not positive definite for these
models because the Hausman test requires strict
conditions for homoscedasticity, which our model
most likely do not have. To address heteroscedasti-
city, we used robust standard errors.
SFA has been used for efficiency comparisons in
health care [26]. SFA has appeared only once in the
peer-reviewed literature to compare efficiency of
health care in OECD countries; however, the compa-
rison focused on hospitals [27]. SFA is a parametric
approach that imposes a functional form (i.e., Cobb-
Douglas production function estimated as a log-linear
model) on the relationship between the inputs and
outputs [28]. We tried to estimate a SFA models with
maximum likelihood techniques [29], but after trying
multiple versions of the model with different arrays
of variables, we could not reach convergence. Instead
we used a less data intensive least squares approach,
which has been shown to provide reliable results
[30, 31].
The SFA is often preferred over a non-parametric
approach, data envelopment analysis (DEA), which is
Table 2 Country ranks when estimating total life expectancy (years)
Estimation approach Model A Model B Model C Model D
Fixed Effect w/ Country US Rank 6/25 16/20 9/14 13/14
Top Rank Country New Zealand Slovenia Japan Japan
Sample Size 394 203 133 133
Fixed Effects w/ Country and Year US Rank 12/25 14/20 7/14 8/14
Top Rank Country Japan Israel Australia Australia
Sample Size 394 203 133 133
Stochastic Frontier Analysis US Rank 15/23 10/18 11/13 12/13
Top Rank Country Japan Japan Japan Japan
Sample Size 393 201 133 133
Independent Variables Total physicians per 1,000 capita x x x x
YPLL from assaults per 100,000 capita x x x x
YPLL from self-harm per 100,000 capita x x x x
YPLL from transportation per 100,000 capita x x x x
YPLL from alcohol use per 100,000 capita x x x x
MRI scanners per million population x
CT scanners per million population x
Calories consumed per capita per day
(adjusted for average population height in cm)
x x
Percent of population (15 years and older) smoking daily x x
Total (mobile + stationary) nitrogen dioxide
(measured in cubic tons) per square mile of land
x x
GDP per capita, PPP
(Deflated to 2005 Dollars)
x
NOTE: Smoking variable is lagged by 5 years; YPLL = Years of potential life lost; CT = computed tomography; MRI =magnetic resonance imaging; GDP = Gross
Domestic Product; PPP = Purchasing Power Parities
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limited in the number of allowable inputs and does
not separate out “noise” from the inefficiency term
[32]. SFA assumes a random disturbance term that is
normally distributed and a technical inefficiency term
that has a strictly non-negative distribution. We as-
sumed a half-normal distribution of the inefficiency
term, which is a common yet narrow assumption.
The choice in the distribution of the inefficiency term
has been found to have a negligible influence on em-
pirical results [12]. We allowed technical inefficiency
to vary over time rather than stay constant as in the
FE models. In SFA, the most efficient country has an
inefficiency residual term that is equal to zero; all
other countries with an inefficiency residual term less
than zero are considered less efficient.
For ranking, within a model, the country with the
largest positive residual (or zero in the SFA model) is
ranked number one. The remaining countries are
ordered based on the distance of their residual from the
number one ranked country; the larger the difference in
residuals from the number one country, the lower the
country rank.
Results
In Table 2, we show the US rankings for 12 out of 36
models - four different sets of input variables by three
different estimation approaches – estimating total years of
life expectancy at birth of the population. Japan ranks first
for over half of the models presented in Table 2, and for
75 % of the models estimating female life expectancy at
age sixty. The US rank varies considerably going from as
high as sixth out of 25 to as low as thirteenth out of 14
countries. Across all 36 models, we find a generally
dispersed picture with the US ranking near the center
(Tables 3, 4 and 5). The US never ranks higher than fifth
out of all 36 models, but is also never the very last ranked
country though it was close in several models. The SFA
estimation approach produces the most consistent lead
country, but the remaining countries did not maintain a
steady rank.
Table 3 Country ranks when estimating total life expectancy (years)
Country Model A Model B Model C Model D
FE FE full SFA FE FE full SFA FE FE full SFA FE FE full SFA
Australia 5 4 4 5 3 3 7 1 3 4 1 4
Austria 17 13 10 15 12 4 13 8 7 12 7 10
Belgium 12 9 11 5 12 10 11 12 9
Czech Republic 22 21 19 17 14
Denmark 21 19 16 14 13 13 12 13 12 14 14 13
Estonia 24 25 23 18 18 17
Finland 8 15 13 10 10 7 11 6 6 7 6 6
Germany 19 14 9 6 11 8 10 11 8
Hungary 25 24 22 19 19 18
Iceland 11 5 2 11 5 2 8 2 2 5 2 2
Israel 18 8 7 6 1 5
Italy 9 2 13 4
Japan 3 1 1 8 2 1 1 4 1 1 4 1
Korea 2 17 18 4 11 12 2 10 13 2 9 11
Luxembourg 4 10 12 7 8 8
Mexico 16 20 21 9 15 16
New Zealand 1 6 8 2 6 6 3 3 5 3 3 5
Norway 15 11 6
Poland 20 22 20 12 16 15 14 14 8 13
Slovak Republic 23 23 20 20
Slovenia 7 18 17 1 9 11
Spain 10 3 5
Sweden 14 7 3 10 5 4 6 5 3
United Kingdom 13 16 14 3 7 9 4 9 9 9 10 7
United States 6 12 15 16 14 10 9 7 11 13 8 12
Note: FE = country fixed effects; FE Full = country and time fixed effects; SFA = stochastic frontier analysis
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In Tables 6 and 7, we see that physicians per capita is
consistently significant in the country only FE models,
but loses significance in the country and time FE and
SFA models. YPLL from transportation is the only vari-
able to be significant across the three estimation ap-
proaches in Model A, but it loses significance with the
addition of technology, environmental, lifestyle, and eco-
nomic variables. Generally no consistent pattern emerges
in the significance of the input variables, and the signifi-
cance of the inputs appear to be sensitive to the variation
in the set of countries in the analysis.
We note that the inclusion of GDP per capita
(Model D) does not add much explanatory power to
the models and loses its significance with the addition
of time fixed effects. Including GDP raises concerns
about endogeneity. A long literature exists pursuing
this line of causation that generally states that when
health status improves, workers may be more pro-
ductive, raising GDP [33]. To gauge how rankings
perform relative to a measure of real resources in
health care, we plotted the ranks against our main
health resources variable - number of physicians per
1,000 capita. In Figure 1, we plot the rankings from
the SFA estimation of Model A and find a generally
dispersed picture with the US near the center. The
pattern generally holds across all models.
Sensitivity analysis
We tried alternative input measures to estimate life ex-
pectancy. We found that our results were not sensitive
to the height and land mass adjustments to calories and
pollution, respectively. Although physicians per 1,000
capita is a very common metric in estimating health
system efficiency, we lost about twenty percent of our
sample by using this metric. We tested total health em-
ployment as an alternative, but the ranking results for
the countries in both models remained about the same.
We chose physicians over total health employment given
the more definitive nature of counting physicians versus
the more ambiguous definition of a “health employee”;
Table 4 Country ranks when estimating male life expectancy at age 60 (years)
Country Model A Model B Model C Model D
FE FE full SFA FE FE full SFA FE FE full SFA FE FE full SFA
Australia 5 3 5 5 5 4 13 1 2 9 1 3
Austria 17 16 8 16 13 7 10 9 7 14 9 8
Belgium 11 13 13 4 13 11 8 13 11
Czech Republic 22 22 20 17 17 15
Denmark 21 19 17 15 15 9 7 12 12 12 12 12
Estonia 23 25 23 19 19 17
Finland 9 15 16 11 11 10 14 7 10 13 6 10
Germany 19 17 10 5 10 8 6 10 6
Hungary 24 24 22 18 18 18
Iceland 10 4 1 10 6 1 11 2 1 7 2 1
Israel 18 6 3 6 1 3
Italy 15 9 14 8
Japan 3 1 4 8 3 2 2 3 4 1 4 4
Korea 2 18 19 7 12 14 1 11 13 2 11 13
Luxembourg 7 11 15 9 10 11
Mexico 4 5 11 1 2 12
New Zealand 1 2 9 2 3 5 8 4 5 3 3 5
Norway 16 12 7
Poland 20 21 21 12 16 16 9 14 5 14
Slovak Republic 25 23 29 29
Slovenia 8 20 18 4 14 13
Spain 13 7 6
Sweden 14 10 2 12 5 3 10 5 2
United Kingdom 12 14 14 3 7 6 3 8 9 4 8 7
United States 6 8 12 13 9 8 6 6 6 11 7 9
Note: FE = country fixed effects; FE Full = country and time fixed effects; SFA = stochastic frontier analysis
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for example, some countries include social assistance
workers as health employees. We tested number of
physician visits but the US was missing one-third of the
years of observations. We tried physician-to-nurse and
general practitioner-to-specialist ratios, but given that
countries did not provide consistent years of data for
these variable sets, many countries were excluded. We
tested the inclusion of acute care beds as well as total
number of hospital discharges (two variables that were
also highly correlated with each other), but found that
the measure was not significant in any of our models
and its inclusion did not noticeably change the rankings.
We tested alcohol consumption as an alternative to
YPLL from alcohol consumption, but again generally
found the same results. We ideally would have more
measures for chronic disease and related risk factors,
but data availability was limited. For example, obesity
would seem to be an important measure, but each coun-
try collects the data differently (i.e., measured versus
self-report) and the data has only been reported for a
few years. We also would like to lag cigarette use over
more years, but again the years of data availability is
limited. Despite these data limitations, our findings
remained consistent. The rankings varied based on the
set of countries, years and input variables included.
We also tried different estimation approaches. In a re-
sidual analysis, we saw a clear time trend in the random
disturbance from the FE models. We tested and found
evidence for serial correlation in our FE models. Al-
though the traditional corrections for serial correlation
are available, the latest literature advises against these
corrections in the absence of strong prior on the nature
of the serial correlation and the use of robust standard
errors instead [34]. With the SFA model, we see a more
randomly dispersed pattern to the error term although
there is a slight upward drift. While we control for het-
eroskedasticity in the FE models, we do not have a
mechanism to correct for heteroskedasticity in the SFA
models, which may bias our coefficients but not neces-
sarily the relative rankings. SFA also requires at least
Table 5 Country ranks when estimating female life expectancy at age 60 (years)
Country Model A Model B Model C Model D
FE FE full SFA FE FE full SFA FE FE full SFA FE FE full SFA
Australia 5 3 2 7 3 2 7 1 4 4 1 6
Austria 13 11 9 14 10 6 10 8 5 9 7 7
Belgium 11 5 6 3 11 2 11 12 2
Czech Republic 23 22 21 18 18 16
Denmark 22 20 18 17 15 13 14 14 13 14 14 13
Estonia 20 23 22 16 17 15
Finland 8 13 8 10 8 3 9 5 3 6 5 3
Germany 17 14 11 6 10 9 10 11 8
Hungary 24 25 23 19 19 18
Iceland 14 8 7 13 9 4 12 4 8 7 4 10
Israel 21 15 13 12 4 11
Italy 10 3 11 2
Japan 1 1 1 2 1 1 1 2 1 1 2 1
Korea 2 16 17 5 13 8 2 9 10 3 9 5
Luxembourg 4 7 10 4 5 5
Mexico 12 19 19 6 14 17
New Zealand 3 6 12 3 6 10 4 3 6 2 3 4
Norway 15 10 5
Poland 16 21 20 9 16 14 8 12 5 8
Slovak Republic 25 24 20 20
Slovenia 9 17 16 1 11 9
Spain 6 2 2
Sweden 18 12 4 13 6 7 8 6 9
United Kingdom 19 18 15 8 7 12 11 13 11 13 13 11
United States 7 9 14 15 12 7 5 7 12 12 10 12
Note: FE = country fixed effects; FE Full = country and time fixed effects; SFA = stochastic frontier analysis
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Table 6 Coefficients estimating total life expectancy (years) – models A and B
Model A Model B
FE FE full SFA FE FE full SFA
Total physicians per 1,000 capita 0.065*** 0.010 0.001 0.049** 0.018 0.004
(0.017) (0.013) (0.003) (0.016) (0.013) (0.005)
YPLL from assaults per 100,000 capita −0.003 −0.003 −0.000 0.003 −0.001 −0.000
(0.005) (0.002) (0.000) (0.003) (0.001) (0.000)
YPLL from self-harm per 100,000 capita −0.012 0.004 −0.001 −0.005 0.008 −0.000
(0.009) (0.010) (0.002) (0.006) (0.005) (0.002)
YPLL from transportation per 100,000 capita −0.039*** −0.018* −0.005*** −0.018* −0.010 −0.001
(0.008) (0.008) (0.001) (0.008) (0.006) (0.001)
YPLL from alcohol use per 100,000 capita −0.001 0.000 −0.004*** −0.005 −0.004* −0.003***
(0.003) (0.002) (0.000) (0.004) (0.002) (0.001)
MRI scanners per million population 0.010*** 0.003 −0.002*
(0.002) (0.002) (0.001)
CT scanners per million population 0.011*** 0.006** −0.001
(0.003) (0.002) (0.001)
Year
1991 0.003 −0.002
(0.002) (0.003)
1992 0.005* −0.004
(0.002) (0.003)
1993 0.006 −0.005
(0.003) (0.004)
1994 0.009** −0.004
(0.003) (0.004)
1995 0.009* −0.002
(0.003) (0.005)
1996 0.013*** 0.002
(0.003) (0.005)
1997 0.017*** 0.004
(0.004) (0.006)
1998 0.018*** 0.006
(0.005) (0.006)
1999 0.020*** 0.010
(0.004) (0.006)
2000 0.026*** 0.014*
(0.005) (0.007)
2001 0.029*** 0.018*
(0.005) (0.007)
2002 0.031*** 0.019*
(0.005) (0.007)
2003 0.032*** 0.019*
(0.005) (0.007)
2004 0.036*** 0.023**
(0.006) (0.008)
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two time observations for each country, so we would
lose Italy and the Slovak Republic.
Discussion
Our study sheds light on the fragility of health system
rankings by using a large panel and applying the latest
efficiency modeling techniques. While we find that the
US tends to be in the middle to lower third of country
rankings, the US is never the last ranked country and is
occasionally near the top ranked countries. Rankings
vary considerably when different variables are included
in the model and also when different statistical ap-
proaches are used. Among the statistical approaches pre-
sented in this study, the SFA model is the preferred
given the distribution properties of the error term and
the allowance of technical efficiency to vary over time.
As a result, the rankings resulting from SFA may be
considered superior over the other statistical approaches.
Although health care spending measures are often
included in discussions around health system perform-
ance, we exclude this variable from our analysis since it
conflates the discussion around prices versus quantity. We
included measure of quantity (e.g., health service utiliza-
tion and resources), but the OECD Health Data does not
have any measures for prices (e.g., medical price index or
medical care purchasing power parities exchange rate).
Given the complexities of what price captures such as dif-
ferences in labor markets, health care financing and
organization and quality of care, health care spending ser-
iously overstates the real resources used in health care in
some countries, especially in the US [35].
There are three limitations with our analysis. First we
were limited in the statistical methods that are possible,
given data problems. Second, though we have better
controls for environmental, lifestyle and behavioral risk
factors than past literature, these controls are imperfect.
Many important variables are not generally available or
are not well measured. Third, while closer to measuring
health care system efficiency than previous efforts, our
results still capture efficiency differences that are beyond
the health care system.
Suggestions for an international data repository
The OECD has been a trusted source of data to compare
industrialized countries. They have accomplished the
significant and highly valuable task of harmonizing sec-
ondary data collected in different manners across coun-
tries with different capacities to share data. We put forth
two recommendations for improvement. First, we rec-
ommend a permanent public repository of the data.
Every year the OECD releases a new set of historical
data, which includes revisions to older OECD releases.
While this a tremendous asset, there is also an archival
concern. Data or specific countries and years that may
have been available in the past via the OECD data set
are sometimes no longer to be found in new releases.
These revisions need to be carefully tracked and docu-
mented to protect confidence in the reliability of the
data.
Second, we recommend that the OECD invest in a
federated data locater system where the location of inde-
pendent data sources from countries are clearly
Table 6 Coefficients estimating total life expectancy (years) – models A and B (Continued)
2005 0.038*** 0.025**
(0.006) (0.008)
2006 0.041*** 0.027**
(0.006) (0.008)
2007 0.043*** 0.027**
(0.006) (0.009)
2008 0.043*** 0.028**
(0.007) (0.01)
2009 0.046*** 0.031**
(0.007) (0.01)
2010 0.048*** 0.035**
(0.009) (0.01)
Constant 4.587*** 4.397*** 4.389*** 4.321***
(0.072) (0.063) (0.071) (0.045)
Observations 394 394 393 203 203 201
Adjusted R-squared 0.820 0.910 0.874 0.935
Note: FE = country fixed effects; FE Full = country and time fixed effects; SFA = stochastic frontier analysis; YPLL = Years of potential life lost; CT = computed
tomography; MRI = magnetic resonance imaging
*p < 0.05, **p < 0.01, ***p < 0.001
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Table 7 Coefficients estimating total life expectancy (years) – models C and D
Model C Model D
FE FE full SFA FE FE full SFA
Total physicians per 1,000 capita 0.061* 0.041* 0.007 0.047 0.039* 0.008
(0.028) (0.018) (0.007) (0.022) (0.017) (0.006)
YPLL from assaults per 100,000 capita 0.000 0.000 −0.000 0.001 0.000 −0.000
(0.001) (0.001) (0.001) (0.001) (0.001) (0.001)
YPLL from self-harm per 100,000 capita −0.002 0.001 −0.002 −0.002 0.001 0.000
(0.004) (0.004) (0.001) (0.005) (0.005) (0.002)
YPLL from transportation per 100,000 capita −0.026* −0.013 −0.002 −0.021* −0.013 −0.002
(0.009) (0.007) (0.001) (0.007) (0.008) (0.001)
YPLL from alcohol use per 100,000 capita −0.003* −0.001 0.000 −0.001 −0.000 0.000
(0.001) (0.002) (0.001) (0.002) (0.002) (0.001)
Calories consumed per capita per day
(adjusted for average population height in cm)
0.048 0.002 −0.012 0.065 0.009 −0.022
(0.025) (0.034) (0.012) (0.038) (0.034) (0.012)
Percent of population (15 years and older) smoking daily −0.025* −0.004 0.002 −0.017* −0.004 0.002
(0.011) (0.006) (0.002) (0.007) (0.006) (0.002)
Total (mobile + stationary) nitrogen dioxide
(measured in cubic tons) per square mile of land
−0.008 0.018* 0.004 0.004 0.018* 0.003
(0.009) (0.006) (0.003) (0.007) (0.006) (0.003)
GDP per capita, PPP, deflated to 2005 dollars 0.038*** 0.008 0.017**
(0.007) (0.007) (0.006)
Year
1991 0.000 0.000
1992 0.000 0.000
1993 0.000 0.000
1994 0.000 0.000
1995 −0.029*** −0.027***
(0.004) (0.005)
1996 −0.026*** −0.024***
(0.004) (0.004)
1997 −0.023*** −0.022***
(0.004) (0.004)
1998 −0.021*** −0.019***
(0.003) (0.003)
1999 −0.017*** −0.016***
(0.003) (0.003)
2000 −0.015 −0.014***
(0.002) (0.002)
2001 −0.012 −0.011***
(0.001) (0.002)
2002 −0.011*** −0.010***
(0.001) (0.001)
2003 −0.010*** −0.009***
(0.001) (0.011)
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identified for further analysis. The current process of
manual harmonization of data sometime leaves out
existing data. For example, the 2013 OECD Health Data
did not include the number of physicians per 1,000
capita for the years of 2009 and 2010 for the US. Our
team manually extracted these data points from the ori-
ginal source cited in the OECD in order to include these
data points in our analysis.. Future analysts of OECD
will be well served by data systems able locate and
harmonize data automatically while allowing the data to
be maintained and housed autonomously by member
countries.
Conclusion
In this study, we addressed criticisms that we and others
have made regarding the validity of international rankings
by using a wide array of statistical methods and more in-
clusive data. Our results do not refute prevailing belief in
the literature that the US is a big health care spender and
does not consistently deliver the highest quality health
care or achieve the best health outcomes. Depending on
the estimation approach and choice of variables, however,
the US does rank high in technical efficiency. The lack of
consistency in our results suggest that users of the existing
set of published rankings proceed with caution.
With the change in US investment in the health econ-
omy following the ACA and HITECH Act, change in ef-
ficiency will be critical to measure. Doing so consistently
must be a priority for accurate comparison of countries
health care systems in the future.
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